Copley Scientific

Call Website

Copley Scientific The company is also active in detergent testing.

Founded in 1946, Copley Scientific is recognised as the world’s leading manufacturer and supplier of inhaler test equipment and is a major provider of test systems for other pharmaceutical dosage forms.

One less step. One less risk.Small improvements to everyday testing workflows can make a meaningful difference in the la...
14/10/2026

One less step. One less risk.

Small improvements to everyday testing workflows can make a meaningful difference in the laboratory.

With the new Critical Flow Controller TPK 200iX, the 7-series vacuum pumps can be activated automatically when a test is initiated, removing reliance on manual pump operation.

Traditionally, vacuum pumps have required manual activation before inhaler testing begins. This can lead to unnecessary pump runtime, or if activation is forgotten, tests being initiated without vacuum, potentially resulting in voided assessments, wasted product and additional cleaning.

⚙️Discover how automatic pump control can benefit your laboratory:
https://bit.ly/4yRDYDS

This week, we're heading across the pond to the US, where our CEO, Jamie Clayton, will be representing Copley Scientific...
12/10/2026

This week, we're heading across the pond to the US, where our CEO, Jamie Clayton, will be representing Copley Scientific as a panellist at Advancing Bioequivalence Frameworks for Inhalation Drug Products from 14–15 October.

Co-hosted by the FDA and the Center for Research on Complex Generics (CRCG), the workshop brings together experts from industry, academia and regulatory bodies to explore advances in in vitro, in vivo and in silico approaches to bioequivalence assessment.

Jamie will share his expertise in OINDP testing, contributing to discussions on the evolving analytical and regulatory considerations shaping inhaler testing strategies and workflows.

As approaches to demonstrating bioequivalence continue to evolve, understanding what these developments mean for testing practice is increasingly important.

That’s also the focus of our upcoming webinar on 28 October, From Guidance to Practice: Navigating Revised FDA PSGs for Inhaled Products, focusing on recent guidance revisions and their practical implications for inhaler testing.

🔗 Register for the webinar: https://bit.ly/4rQbiZa

There’s still time to register for our upcoming webinar on the FDA’s revised Product-Specific Guidances (PSGs) for gener...
08/10/2026

There’s still time to register for our upcoming webinar on the FDA’s revised Product-Specific Guidances (PSGs) for generic inhaled products.

Join us on Wednesday 28 October as we take a practical look at what the latest revisions could mean for OINDP development and bioequivalence assessment.

We’ll explore:
• How to approach the proposed in vitro studies
• Key considerations for study design and method suitability
• What regulators may look for when assessing the resulting data

📅 Wednesday 28 October
⏰ 9:00am or 5:00pm GMT

Secure your place to find out how the changes affect you: https://bit.ly/4rQbiZa

🫁Inhaled drug development is evolving and so are the questions testing strategies need to answer.The recent Intertek Inh...
06/10/2026

🫁Inhaled drug development is evolving and so are the questions testing strategies need to answer.

The recent Intertek Inhaled & Nasal Biologics DNA Forum 2026 brought together discussions spanning emerging biologics, novel formulations and new approaches to respiratory delivery.

For us, one of the most interesting themes was what increasing product complexity could mean for aerosol testing; from formulation and device considerations to the role of different performance assessments throughout development.

In our latest carousel, we share the key points that stood out and consider what they could mean for your inhaler testing workflows.

➡️Swipe through for our key takeaways.

📢 USP Disintegration UpdateFrom 1 October 2026, the revised USP Disintegration chapter comes into effect, introducing ...
01/10/2026

📢 USP Disintegration Update

From 1 October 2026, the revised USP Disintegration chapter comes into effect, introducing a new Test B basket-rack assembly for dosage forms greater than 18 mm on their longest axis.

✅ Our DTGi Disintegration Tester Series already supports the updated requirements.

At Copley, we continuously monitor pharmacopoeial developments, helping ensure our testing solutions keep pace with our evolving requirements.

⚙️ Make sure your disintegration testing is ready
Discover how the DTGi Series supports compliant disintegration testing: https://bit.ly/4iZGzXh

🔎 Review the USP update
See the revised requirements directly from USP: https://www.usp.org/harmonization-standards/pdg/general-methods/disintegration

Last weekend, members of the Copley Scientific team took on the Robin Hood Mini Marathon and Half Marathon in support of...
30/09/2026

Last weekend, members of the Copley Scientific team took on the Robin Hood Mini Marathon and Half Marathon in support of Asthma + Lung UK.

It was a brilliant day of teamwork, determination and plenty of encouragement, with colleagues coming together to take on the challenge for a cause that has a particularly strong connection to the work we do.

A huge well done to everyone who took part, supported the team and helped make the day such a success; a great example of what can be achieved through hard work and team spirit.

Well done, Team Copley! 👏🏃‍♀️🏃‍♂️

It’s been a busy start to the autumn conference season for our team in China, with three events across three cities in j...
25/09/2026

It’s been a busy start to the autumn conference season for our team in China, with three events across three cities in just three weeks: the CMC Inhalation Preparation Conference in Suzhou, Aptar’s IDDS conference in Beijing, and the 3rd Symposium on Key Technologies of Inhalation Preparations in Nanjing.

Across all three events, Dr Anny Shen presented on a key theme shaping inhaled drug development today: generating more patient-relevant in vitro data.

Dr Shen’s presentations explored IVIVC testing using Idealised Throats and realistic breathing profiles with the Breathing Simulator BRS 300i, alongside dissolution testing with the Inhaled Dissolution Apparatus™ IDA and its growing relevance within Product-Specific Guidances.

It was a valuable opportunity to connect with colleagues across the inhalation community, exchange perspectives on current testing challenges, and continue the conversation around more clinically relevant approaches to OINDP development.

Want to explore how more representative in vitro testing can help improve IVIVCs?

Read our 3-part blog series here: https://bit.ly/4z1LT1g

An unexpected test result can be just the tip of the iceberg.When poor control of variability leads to an OOS or OOT res...
23/09/2026

An unexpected test result can be just the tip of the iceberg.

When poor control of variability leads to an OOS or OOT result, the consequences can quickly accumulate:
• Investigation
• Repeat testing
• Greater demand on laboratory resource
• Reduced productivity
• Reduced confidence in the data
• Potential development delays

One reason is that greater variability can make small but meaningful differences harder to detect, making confident conclusions harder to draw.

Temperature, relative humidity and electrostatics are potential sources of variability that can be controlled during inhaler testing.

Reducing unnecessary variability means more than improving analytical performance. It can mean fewer resources spent explaining unexpected results and more confidence in the data used to make decisions.

Could environmental variability be adding hidden cost to your testing?

Explore the hidden impact of environmental variability on inhaler testing: https://bit.ly/4ipnPQK

What does connected inhaler testing actually mean?For Copley, it means more than moving data between systems. It is abou...
21/09/2026

What does connected inhaler testing actually mean?

For Copley, it means more than moving data between systems. It is about bringing software, equipment and workflow information together to support greater control, consistent testing and clearer traceability.

Inhalytix®+ and the new Critical Flow Controller TPK 200iX show how this works in practice.

Approved methods and authorised users can be managed centrally in Inhalytix+ and made available on the TPK 200iX, with supported operating information and reports returned to Inhalytix+ as part of the digital test record.

This gives laboratories clearer visibility of how the method, user, equipment activity and resulting record fit together.

Swipe through to see how the workflow comes together. 👉

Explore connected inhaler testing: https://www.copleyscientific.com/inhaler-testing/connected-inhaler-testing/?utm_source=facebook&utm_medium=social&utm_campaign=connected-inhaler-testing

The FDA’s updated Product-Specific Guidances (PSGs) introduce new considerations for the development and bioequivalence ...
17/09/2026

The FDA’s updated Product-Specific Guidances (PSGs) introduce new considerations for the development and bioequivalence assessment of generic inhaled products.

What do the latest revisions mean for your development programme? How should the proposed in vitro studies be approached? And what will regulators be looking for when assessing study design, method suitability and the resulting data?

Join our upcoming webinar to explore what the latest PSG revisions mean in practice, including:
• How to approach the proposed in vitro studies
• Key considerations for study design and method suitability
• What regulators may look for when assessing the resulting data

📅 Wednesday 28th October
⏰ 9:00am or 5:00pm GMT

Register your place today for a practical look at what the latest FDA PSG updates mean for OINDP development: https://bit.ly/4haUirC

Address

Colwick Quays Business Park
Nottingham
NG42JY

Opening Hours

Monday 8:30am - 4:30pm
Tuesday 8:30am - 6:30pm
Wednesday 8:30am - 4:30pm
Thursday 8:30am - 4:30pm
Friday 8:30am - 4:30pm

Telephone

+441159616229

Website

Alerts

Be the first to know and let us send you an email when Copley Scientific posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Shortcuts

Sponsored

Share